Indication
Rhabdoviridae Infections
1 clinical trial
3 products
Clinical trial
A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure RisksStatus: Completed, Estimated PCD: 2022-06-24
Product
Rabies VaccineProduct
SYN023Product
Human Rabies Immune Globulin